Omnicell Inc (OMCL)

Omnicell Inc (NASDAQ:OMCL) is a $1.9 billion in market value member of the Health Care Technology GICS industry group where the stock's Portfolio Grader ranking places it 3 among the 24 companies in this industry group, putting in the top quartile. OMCL is ranked in the top quartile of the sector with a ranking of 81 among the 781 companies in the sector and number 475 in the 5000 company Portfolio Grader company universe.

Omnicell Inc (NASDAQ:OMCL) is a $1.8 billion in market value constituent of the Health Care Technology GICS industry group where Portfolio Grader's current ranking for OMCL puts it 3 among the 24 companies in this industry group, giving it a well above-average position. OMCL is ranked in the top quartile of the sector with a ranking of 81 among the 781 companies in the sector and number 474 in the 5000 company Portfolio Grader company universe.

Omnicell Inc (NASDAQ:OMCL) is one of the 782 companies in the GICS Health Care sector, and a constituent of the 24 company Health Care Technology GICS industry group within this sector. OMCL has a market value of $1.8 billion which is in the top half of its industry group. Currently, the stock's Portfolio Grader ranking places it 3 among the 24 companies in this industry group, placing it among the leaders; among the sector leaders with a ranking of 72 among the 782 companies in the sector, and number 489 in the nearly 5,000 company Portfolio Grader universe.

Omnicell Inc (NASDAQ:OMCL) ranks in the top half of its industry group, Health Care Technology, and in the top 25% of its sector group, Health Care, with a market value of $1.9 billion. From an investment attractiveness viewpoint, OMCL is ranked in the top decile of the sector with a ranking of 14 among the 785 companies in the sector; the stock's current Portfolio Grader score places it 1 among the 24 companies in this industry group, positioning it among the leaders and number 113 in the 5000 company Portfolio Grader company universe.

The current recommendation of Buy for Omnicell Inc (NASDAQ:OMCL) has been derived by using Louis Navellier's investing approach and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking OMCL has had from Portfolio Grader for 3 months.

Portfolio Grader currently ranks Omnicell Inc (NASDAQ:OMCL) a Buy. Using Louis Navellier's investing methods, this analytical tool researches stocks by employing proprietary fundamental and quantitative metrics. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

Omnicell Inc (NASDAQ:OMCL) is a constituent of the 26 company Health Care Technology GICS industry group, which is a segment of the 783 company GICS Health Care sector. The market value of OMCL is $1.9 billion which places it in the top half of its industry group. Currently, the stock's Portfolio Grader ranking places it 6 among the 26 companies in this industry group, giving it a well above-average position; in the top quartile of the sector with a ranking of 137 among the 783 companies in the sector, and number 1,034 in the nearly 5,000 company Portfolio Grader universe.

Currently, Omnicell Inc (NASDAQ:OMCL) has a Buy using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking OMCL has had from Portfolio Grader for 2 months.

Currently, Omnicell Inc (NASDAQ:OMCL) has a Buy using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking OMCL has had from Portfolio Grader for 2 months.